Ophthalmic Drug Delivery Interview With Michael O’Rourke, CEO of ReVana Therapeutics At OIS@ASRS

Ophthalmology Innovation Summit TV Host: Firas M. Rahhal, MD, Partner – Exsight Ventures / Retina Vitreous Associates Medical Group speaks with Michael O’Rourke about ReVana’s innovative photo cross-linking sustained drug delivery technology.

REGISTER for our next ophthalmology conference today.

Interview takes places at Ritz-Carlton Chicago on July 25, 2019.